文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

HIV RNA筛查降低接受长效卡博特韦预防HIV感染者整合酶链转移抑制剂耐药风险

HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.
PubMed 文献 · J Infect Dis · 2022-01-01

HPTN 083试验显示长效卡博特韦(CAB-LA)暴露前预防优于替诺福韦酯/恩曲他滨。本研究对7例HIV感染者的样本进行单基因组测序,检测整合酶链转移抑制剂(INSTI)耐药相关突变(RAMs)。结果显示,敏感HIV RNA检测可在主要INSTI RAMs出现前识别感染,提示早期检测可能降低耐药风险。

要点

  • 在7例接受CAB-LA预防的HIV感染者中均检测到主要INSTI RAMs。
  • HIV RNA检测在4例中于主要INSTI RAMs出现前识别感染,在1例中于额外主要RAMs累积前识别。
  • 大多数INSTI RAMs在病毒载量低且CAB浓度高时早期检出。

核心结论

  • 使用CAB-LA暴露前预防时,敏感RNA检测早期发现HIV感染可能允许更早启动治疗,从而可能降低INSTI耐药风险。
  • 需要进一步研究评估CAB-LA暴露前预防中HIV RNA检测的价值和可行性。

研究设计与样本

  • 对5例既往已识别INSTI RAMs和2例无既往基因型结果的参与者中病毒载量<500拷贝/mL的样本进行单基因组测序以检测INSTI RAMs。

主要发现

  • 在全部7例中均检测到主要INSTI RAMs。
  • HIV RNA检测在4例中于主要INSTI RAMs出现前识别感染,在1例中于额外主要INSTI RAMs累积前识别。
  • 大多数INSTI RAMs在病毒载量低且CAB浓度高时早期检出。

临床怎么用

  • 作者认为,使用CAB-LA暴露前预防时,敏感RNA检测早期发现HIV感染可能允许更早启动治疗,从而可能降低INSTI耐药风险。
  • 作者指出需要进一步研究评估CAB-LA暴露前预防中HIV RNA检测的价值和可行性。

局限性

  • 需要进一步研究评估CAB-LA暴露前预防中HIV RNA检测的价值和可行性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The HPTN 083 trial demonstrated that long-acting cabotegravir (CAB-LA) was superior to tenofovir-disoproxil fumarate/emtricitabine for human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP). Integrase strand transfer inhibitor (INSTI) resistance-associated mutations (RAMs) were detected in some participants with HIV infection. We used a low viral load INSTI genotyping assay to evaluate the timing of emergence of INSTI RAMs and assessed whether HIV screening with a sensitive RNA assay would have detected HIV infection before INSTI resistance emerged. METHODS: Single-genome sequencing to detect INSTI RAMs was performed for samples with viral loads <500 copies/mL from 5 participants with previously identified INSTI RAMs and 2 with no prior genotyping results. RESULTS: Major INSTI RAMs were detected in all 7 cases. HIV RNA testing identified infection before major INSTI RAMs emerged in 4 cases and before additional major INSTI RAMs accumulated in 1 case. Most INSTI RAMs were detected early when the viral load was low and CAB concentration was high. CONCLUSIONS: When using CAB-LA PrEP, earlier detection of HIV infection with a sensitive RNA assay may allow for earlier treatment initiation with the potential to reduce INSTI resistance risk. Further studies are needed to evaluate the value and feasibility of HIV RNA testing with CAB-LA PrEP.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Eshleman SH, Fogel JM, Halvas EK, et al. HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention. J Infect Dis. 2022. PMID: 36240386. doi:10.1093/infdis/jiac415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。